210 related articles for article (PubMed ID: 29106031)
21. Comparison of the effects of amlodipine and losartan on blood pressure and diurnal variation in hypertensive stroke patients: a prospective, randomized, double-blind, comparative parallel study.
Kwon HM; Shin JW; Lim JS; Hong YH; Lee YS; Nam H
Clin Ther; 2013 Dec; 35(12):1975-82. PubMed ID: 24296324
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine.
Asmar R; Gosse P; Queré S; Achouba A
Blood Press Monit; 2011 Apr; 16(2):80-6. PubMed ID: 21372694
[TBL] [Abstract][Full Text] [Related]
23. Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure.
Farag SM; Rabea HM; Mahmoud HB
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):407-413. PubMed ID: 30390203
[TBL] [Abstract][Full Text] [Related]
24. Fixed-combination of amlodipine and diuretic chronotherapy in the treatment of essential hypertension: improved blood pressure control with bedtime dosing-a multicenter, open-label randomized study.
Zeng J; Jia M; Ran H; Tang H; Zhang Y; Zhang J; Wang X; Wang H; Yang C; Zeng C
Hypertens Res; 2011 Jun; 34(6):767-72. PubMed ID: 21471971
[TBL] [Abstract][Full Text] [Related]
25. Effect of bedtime administration of blood-pressure lowering agents on ambulatory blood pressure monitoring results: A meta-analysis.
Sun Y; Yu X; Liu J; Zhou N; Chen L; Zhao Y; Li X; Wang J; Cui L
Cardiol J; 2016; 23(4):473-81. PubMed ID: 27296158
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy of fixed combination amlodipine/valsartan in hospitalized patients with hypertensive disease].
Kobalava ZhD; Kotovskaia IuV; Bagmanova NKh; Fediunina EIu; Karaulova IuL
Kardiologiia; 2011; 51(7):27-31. PubMed ID: 21878082
[TBL] [Abstract][Full Text] [Related]
27. 24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study.
Ruilope LM; Heintz D; Brandão AA; Stolt P; Kandra A; Santonastaso M; Khder Y
Blood Press Monit; 2005 Apr; 10(2):85-91. PubMed ID: 15812256
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring.
Sica D; White WB; Weber MA; Bakris GL; Perez A; Cao C; Handley A; Kupfer S
J Clin Hypertens (Greenwich); 2011 Jul; 13(7):467-72. PubMed ID: 21762358
[TBL] [Abstract][Full Text] [Related]
29. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
Sison J; Assaad-Khalil SH; Najem R; Kitchlew AR; Cho B; Ueng KC; Shete A; Knap D
Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
[TBL] [Abstract][Full Text] [Related]
30. Effects of combination therapy with amlodipine and fosinopril administered at different times on blood pressure and circadian blood pressure pattern in patients with essential hypertension.
Meng Y; Zhang Z; Liang X; Wu C; Qi G
Acta Cardiol; 2010 Jun; 65(3):309-14. PubMed ID: 20666269
[TBL] [Abstract][Full Text] [Related]
31. Chronotherapy for hypertension in obstructive sleep apnoea (CHOSA): a randomised, double-blind, placebo-controlled crossover trial.
Serinel Y; Yee BJ; Grunstein RR; Wong KH; Cistulli PA; Arima H; Phillips CL
Thorax; 2017 Jun; 72(6):550-558. PubMed ID: 27974526
[TBL] [Abstract][Full Text] [Related]
32. Treatment of non-dipper hypertension with bedtime administration of valsartan.
Hermida RC; Calvo C; Ayala DE; Fernández JR; Covelo M; Mojón A; López JE
J Hypertens; 2005 Oct; 23(10):1913-22. PubMed ID: 16148616
[TBL] [Abstract][Full Text] [Related]
33. A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.
Rahman M; Greene T; Phillips RA; Agodoa LY; Bakris GL; Charleston J; Contreras G; Gabbai F; Hiremath L; Jamerson K; Kendrick C; Kusek JW; Lash JP; Lea J; Miller ER; Rostand S; Toto R; Wang X; Wright JT; Appel LJ
Hypertension; 2013 Jan; 61(1):82-8. PubMed ID: 23172931
[TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy and safety profile of amlodipine 5 mg/losartan 50 mg fixed-dose combination and amlodipine 10 mg monotherapy in hypertensive patients who respond poorly to amlodipine 5 mg monotherapy: an 8-week, multicenter, randomized, double-blind phase III noninferiority study.
Kang SM; Youn JC; Chae SC; Park CG; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Shin DG; Jeong JW; Yoon JH; Park SH; Kwon J; Cho SY
Clin Ther; 2011 Dec; 33(12):1953-63. PubMed ID: 22136978
[TBL] [Abstract][Full Text] [Related]
35. Bedtime administration of long-acting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension.
Takeda A; Toda T; Fujii T; Matsui N
Clin Exp Nephrol; 2009 Oct; 13(5):467-472. PubMed ID: 19449087
[TBL] [Abstract][Full Text] [Related]
36. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[TBL] [Abstract][Full Text] [Related]
37. [On the way to achieve hypertension treatment goals: results of the open observational program AESCULAP (exforge--clinical safety and efficiency of using a double combination of antihypertensive drugs in patients with uncontrolled blood pressure)].
Chazova IE; Martynyuk TV
Ter Arkh; 2013; 85(9):35-45. PubMed ID: 24261228
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
Ulusoy S; Ozkan G; Konca C; Kaynar K
Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
[TBL] [Abstract][Full Text] [Related]
39. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
[TBL] [Abstract][Full Text] [Related]
40. Office and ambulatory blood pressure-lowering effects of combination valsartan/hydrochlorothiazide vs. hydrochlorothiazide-based therapy in obese, hypertensive patients.
Raij L; Egan BM; Zappe DH; Purkayastha D; Samuel R; Sowers JR
J Clin Hypertens (Greenwich); 2011 Oct; 13(10):731-8. PubMed ID: 21974760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
